BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27611224)

  • 1. The Effect of Commonly Used Excipients on the Epithelial Integrity of Human Cervicovaginal Tissue.
    Hu M; Zhou T; Dezzutti CS; Rohan LC
    AIDS Res Hum Retroviruses; 2016; 32(10-11):992-1004. PubMed ID: 27611224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral Drugs.
    Hijazi K; Cuppone AM; Smith K; Stincarelli MA; Ekeruche-Makinde J; De Falco G; Hold GL; Shattock R; Kelly CG; Pozzi G; Iannelli F
    PLoS One; 2015; 10(6):e0131405. PubMed ID: 26102284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenofovir Inhibits Wound Healing of Epithelial Cells and Fibroblasts from the Upper and Lower Human Female Reproductive Tract.
    Rodriguez-Garcia M; Patel MV; Shen Z; Bodwell J; Rossoll RM; Wira CR
    Sci Rep; 2017 Apr; 8():45725. PubMed ID: 28368028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.
    Rohan LC; Moncla BJ; Kunjara Na Ayudhya RP; Cost M; Huang Y; Gai F; Billitto N; Lynam JD; Pryke K; Graebing P; Hopkins N; Rooney JF; Friend D; Dezzutti CS
    PLoS One; 2010 Feb; 5(2):e9310. PubMed ID: 20174579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of lime juice as a topical microbicide candidate.
    Fletcher PS; Harman SJ; Boothe AR; Doncel GF; Shattock RJ
    Retrovirology; 2008 Jan; 5():3. PubMed ID: 18190686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits.
    Aranha CC; Gupta SM; Reddy KV
    Cytokine; 2008 Jul; 43(1):63-70. PubMed ID: 18513989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.
    Trifonova RT; Pasicznyk JM; Fichorova RN
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4005-10. PubMed ID: 17030562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, regulation, and function of drug transporters in cervicovaginal tissues of a mouse model used for microbicide testing.
    Zhou T; Hu M; Pearlman A; Rohan LC
    Biochem Pharmacol; 2016 Sep; 116():162-75. PubMed ID: 27453435
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Hijazi K; Iannelli F; Cuppone AM; Desjardins D; Caldwell A; Dereuddre-Bosquet N; Scala C; Smith KA; Mukhopadya I; Frank B; Gwozdz G; Santoro F; Grand RL; Pozzi G; Kelly C
    Mol Pharm; 2020 Mar; 17(3):852-864. PubMed ID: 32017579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.
    Gali Y; Delezay O; Brouwers J; Addad N; Augustijns P; Bourlet T; Hamzeh-Cognasse H; Ariën KK; Pozzetto B; Vanham G
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5105-14. PubMed ID: 20921308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
    Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I
    Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
    Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM
    PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of transepithelial electric resistance (TEER) in reconstructed human epidermis by excipients known to permeate intestinal tight junctions.
    Abdayem R; Callejon S; Portes P; Kirilov P; Demarne F; Pirot F; Jannin V; Haftek M
    Exp Dermatol; 2015 Sep; 24(9):686-91. PubMed ID: 25952154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tenofovir on cytokines and nucleotidases in HIV-1 target cells and the mucosal tissue environment in the female reproductive tract.
    Biswas N; Rodriguez-Garcia M; Shen Z; Crist SG; Bodwell JE; Fahey JV; Wira CR
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6444-53. PubMed ID: 25136003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring.
    Keller MJ; Mesquita PM; Marzinke MA; Teller R; Espinoza L; Atrio JM; Lo Y; Frank B; Srinivasan S; Fredricks DN; Rabe L; Anderson PL; Hendrix CW; Kiser PF; Herold BC
    AIDS; 2016 Mar; 30(5):743-51. PubMed ID: 26605514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis.
    Taneva E; Crooker K; Park SH; Su JT; Ott A; Cheshenko N; Szleifer I; Kiser PF; Frank B; Mesquita PM; Herold BC
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1667-75. PubMed ID: 26711762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse.
    Moench TR; Mumper RJ; Hoen TE; Sun M; Cone RA
    BMC Infect Dis; 2010 Nov; 10():331. PubMed ID: 21087496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model.
    Moss JA; Butkyavichene I; Churchman SA; Gunawardana M; Fanter R; Miller CS; Yang F; Easley JT; Marzinke MA; Hendrix CW; Smith TJ; Baum MM
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3759-66. PubMed ID: 27067321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal-cervical epithelial permeability decreases after menopause.
    Gorodeski GI
    Fertil Steril; 2001 Oct; 76(4):753-61. PubMed ID: 11591410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.